188 related articles for article (PubMed ID: 22920193)
21. Application of thin-layer chromatography/infrared matrix-assisted laser desorption/ionization orthogonal time-of-flight mass spectrometry to structural analysis of bacteria-binding glycosphingolipids selected by affinity detection.
Müsken A; Souady J; Dreisewerd K; Zhang W; Distler U; Peter-Katalinić J; Miller-Podraza H; Karch H; Müthing J
Rapid Commun Mass Spectrom; 2010 Apr; 24(7):1032-8. PubMed ID: 20213676
[TBL] [Abstract][Full Text] [Related]
22. Binding of cholera toxin B-subunits to derivatives of the natural ganglioside receptor, GM1.
Lanne B; Schierbeck B; Angström J
J Biochem; 1999 Jul; 126(1):226-34. PubMed ID: 10393343
[TBL] [Abstract][Full Text] [Related]
23. Interaction of pyrene-labeled monosialoganglioside GM1 micelles with cholera toxin.
Picking WD
Biochem Biophys Res Commun; 1993 Sep; 195(3):1153-8. PubMed ID: 8216243
[TBL] [Abstract][Full Text] [Related]
24. Fluorescence analysis of galactose, lactose, and fucose interaction with the cholera toxin B subunit.
Mertz JA; McCann JA; Picking WD
Biochem Biophys Res Commun; 1996 Sep; 226(1):140-4. PubMed ID: 8806604
[TBL] [Abstract][Full Text] [Related]
25. The repertoire of glycosphingolipids recognized by Vibrio cholerae.
Benktander J; Ångström J; Karlsson H; Teymournejad O; Lindén S; Lebens M; Teneberg S
PLoS One; 2013; 8(1):e53999. PubMed ID: 23349777
[TBL] [Abstract][Full Text] [Related]
26. A triple-binding-domain model explains the specificity of the interaction of a sphingolipid activator protein (SAP-1) with sulphatide, GM1-ganglioside and globotriaosylceramide.
Wynn CH
Biochem J; 1986 Dec; 240(3):921-4. PubMed ID: 3827882
[TBL] [Abstract][Full Text] [Related]
27. Analysis of interactions between glycosphingolipids and microbial toxins.
Lingwood CA; Boyd B; Nutikka A
Methods Enzymol; 2000; 312():459-73. PubMed ID: 11070894
[No Abstract] [Full Text] [Related]
28. Insights into binding of cholera toxin to GM1 containing membrane.
Basu I; Mukhopadhyay C
Langmuir; 2014 Dec; 30(50):15244-52. PubMed ID: 25425333
[TBL] [Abstract][Full Text] [Related]
29. Glycosphingolipid (GSL) microdomains as attachment platforms for host pathogens and their toxins on intestinal epithelial cells: activation of signal transduction pathways and perturbations of intestinal absorption and secretion.
Fantini J; Maresca M; Hammache D; Yahi N; Delézay O
Glycoconj J; 2000; 17(3 -4):173-9. PubMed ID: 11201788
[TBL] [Abstract][Full Text] [Related]
30. Shiga toxin glycosphingolipid receptors of Vero-B4 kidney epithelial cells and their membrane microdomain lipid environment.
Steil D; Schepers CL; Pohlentz G; Legros N; Runde J; Humpf HU; Karch H; Müthing J
J Lipid Res; 2015 Dec; 56(12):2322-36. PubMed ID: 26464281
[TBL] [Abstract][Full Text] [Related]
31. The use of cholera toxin as a probe to study the organisation of ganglioside GM1 in membranes.
Critchley DR; Kellie S; Streuli CH; Patel B; Ansell S; Pierce E
Prog Clin Biol Res; 1982; 102 pt A():397-407. PubMed ID: 7167449
[No Abstract] [Full Text] [Related]
32. Glycosphingolipids in vascular endothelial cells: relationship of heterogeneity in Gb3Cer/CD77 receptor expression with differential Shiga toxin 1 cytotoxicity.
Schweppe CH; Bielaszewska M; Pohlentz G; Friedrich AW; Büntemeyer H; Schmidt MA; Kim KS; Peter-Katalinić J; Karch H; Müthing J
Glycoconj J; 2008 May; 25(4):291-304. PubMed ID: 18176841
[TBL] [Abstract][Full Text] [Related]
33. Membrane assembly of Shiga toxin glycosphingolipid receptors and toxin refractiveness of MDCK II epithelial cells.
Legros N; Pohlentz G; Steil D; Kouzel IU; Liashkovich I; Mellmann A; Karch H; Müthing J
J Lipid Res; 2018 Aug; 59(8):1383-1401. PubMed ID: 29866658
[TBL] [Abstract][Full Text] [Related]
34. The binding potential between the cholera toxin B-oligomer and its receptor.
Cai XE; Yang J
Biochemistry; 2003 Apr; 42(14):4028-34. PubMed ID: 12680755
[TBL] [Abstract][Full Text] [Related]
35. Glycosphingolipid structural analysis and glycosphingolipidomics.
Levery SB
Methods Enzymol; 2005; 405():300-69. PubMed ID: 16413319
[TBL] [Abstract][Full Text] [Related]
36. Functional interaction analysis of GM1-related carbohydrates and Vibrio cholerae toxins using carbohydrate microarray.
Kim CS; Seo JH; Cha HJ
Anal Chem; 2012 Aug; 84(15):6884-90. PubMed ID: 22770420
[TBL] [Abstract][Full Text] [Related]
37. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury.
Müthing J; Schweppe CH; Karch H; Friedrich AW
Thromb Haemost; 2009 Feb; 101(2):252-64. PubMed ID: 19190807
[TBL] [Abstract][Full Text] [Related]
38. Shiga toxin induces membrane reorganization and formation of long range lipid order.
Solovyeva V; Johannes L; Simonsen AC
Soft Matter; 2015 Jan; 11(1):186-92. PubMed ID: 25376469
[TBL] [Abstract][Full Text] [Related]
39. Generation of receptor-active, globotriaosyl ceramide/cholesterol lipid 'rafts' in vitro : A new assay to define factors affecting glycosphingolipid receptor activity.
Nutikka A; Lingwood C
Glycoconj J; 2004; 20(1):33-8. PubMed ID: 14973368
[TBL] [Abstract][Full Text] [Related]
40. Intravenous immunoglobulin treatment on anti-GM1 antibodies associated neuropathies inhibits cholera toxin and galectin-1 binding to ganglioside GM1.
Peng W
Immunol Lett; 2012 Apr; 143(2):146-51. PubMed ID: 22289946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
